Excitatory Amino Acid Agonists
"Excitatory Amino Acid Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and activate excitatory amino acid receptors.
| Descriptor ID |
D018690
|
| MeSH Number(s) |
D27.505.519.625.190.200 D27.505.696.577.190.200
|
| Concept/Terms |
Excitatory Amino Acid Agonists- Excitatory Amino Acid Agonists
- Amino Acid Agonist, Excitatory
- Amino Acid Agonists, Excitatory
- EAA Agonists
- Agonists, EAA
- Amino Acids, Excitatory, Agonists
- EAA Agonist
- Agonist, EAA
- Agonists, Excitatory Amino Acid
- Excitatory Amino Acid Agonist
Glutamate Agonists- Glutamate Agonists
- Agonists, Glutamate
- Glutamate Agonist
- Agonist, Glutamate
|
Below are MeSH descriptors whose meaning is more general than "Excitatory Amino Acid Agonists".
Below are MeSH descriptors whose meaning is more specific than "Excitatory Amino Acid Agonists".
This graph shows the total number of publications written about "Excitatory Amino Acid Agonists" by people in this website by year, and whether "Excitatory Amino Acid Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 2000 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Excitatory Amino Acid Agonists" by people in Profiles.
-
The long-term effects of limbic non-convulsive status epilepticus in peri-adolescent rats. Epilepsy Behav. 2024 Dec; 161:110086.
-
Negative allosteric modulation of GluN1/GluN3 NMDA receptors. Neuropharmacology. 2020 10 01; 176:108117.
-
De novo mutations in GRIN1 cause extensive bilateral polymicrogyria. Brain. 2018 03 01; 141(3):698-712.
-
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
-
mGluR5 Exerts Cell-Autonomous Influences on the Functional and Anatomical Development of Layer IV Cortical Neurons in the Mouse Primary Somatosensory Cortex. J Neurosci. 2016 08 24; 36(34):8802-14.
-
Early cardiac electrographic and molecular remodeling in a model of status epilepticus and acquired epilepsy. Epilepsia. 2016 11; 57(11):1907-1915.
-
Rapid changes in expression of class I and IV histone deacetylases during epileptogenesis in mouse models of temporal lobe epilepsy. Exp Neurol. 2015 Nov; 273:92-104.
-
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013 Jun; 16(6):616-22.
-
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration. Ann Neurol. 2013 May; 73(5):667-78.
-
Knockout of Zn transporters Zip-1 and Zip-3 attenuates seizure-induced CA1 neurodegeneration. J Neurosci. 2011 Jan 05; 31(1):97-104.